Stay updated on Apremilast-Dupilumab Combo in Eczema Clinical Trial

Sign up to get notified when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apremilast-Dupilumab Combo in Eczema Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Enrollment status now shows 'No longer looking for participants' and several user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The 'Intervention/Treatment' heading was reformatted and a site revision note 'Revision: v3.6.0' was included.
    Difference
    0.5%
    Check dated 2026-06-12T16:31:28.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5, replacing v3.5.4, indicating a site version update. This change appears to be behind-the-scenes and does not alter study content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-06-05T13:36:59.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added in the page footer, replacing the previous Revision: v3.5.3. This represents a small version update and does not modify study details or primary content on the page.
    Difference
    0.1%
    Check dated 2026-05-15T05:40:50.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page revision indicator from v3.5.2 to v3.5.3 without changing the study content shown in the record.
    Difference
    0.1%
    Check dated 2026-04-24T06:15:27.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:39:23.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T23:01:17.000Z thumbnail image

Stay in the know with updates to Apremilast-Dupilumab Combo in Eczema Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.